Cite Filings / STOK / 0001085146-25-004276

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Stoke Therapeutics, Inc. Filed 2025-07-29 Acc 0001085146-25-004276

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2025-08-06 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-05 4 CHIEF MEDICAL OFFICER sold 4,504 shares at $12.82 ($57,724)
2025-07-29 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-07-15 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…